J&J submits booster request to FDA
Johnson & Johnson on Tuesday submitted its request to the FDA for a booster shot for J&J recipients.
The submission includes data showing that a booster increased protection to 94% against moderate to severe/critical disease in the U.S. (Peak efficacy from one shot is 72% in the U.S.)
The FDA's independent advisory committee is holding a public hearing on J&J boosters on Oct. 15. The FDA may authorize J&J boosters after Oct. 15 and the CDC's recommendation could follow.
-ABC News' Eric M. Strauss